HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Clinical trials for HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to try groundbreaking oral cancer pill
Disease control Recruiting nowThis is the first study in people to test a new oral drug called NKT3964. It aims to see if the drug is safe and can help control advanced cancers that have spread and stopped responding to standard treatments. The study will enroll adults with specific advanced solid tumors, inc…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Breakthrough study tests four drug combos for male breast cancer
Disease control Recruiting nowThis study is testing which of four different hormone therapy combinations works best for men with early-stage breast cancer before surgery. About 60 men will receive one of the treatment combinations for about 4 months to see how their cancer responds. Researchers want to find b…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Jose Pablo Leone • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Can a 10-Week program ease the burden for breast cancer patients?
Symptom relief Recruiting nowThis study is testing whether a 10-week stress reduction and support program is practical and helpful for patients with triple-negative breast cancer. The program teaches relaxation, coping skills, and problem-solving, while also connecting participants with social workers to hel…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC